OncoBay Clinical
Founded Year
2019Stage
Corporate Majority | AcquiredAbout OncoBay Clinical
OncoBay Clinical operates a research organization specializing in immuno-oncology and cellular therapy. It offers full-service custom CRO solutions for pharmaceutical and biotech companies. The company was founded in 2019 and is based in Tampa, Florida. In January 2023, NEUCA acquired a majority stake in OncoBay Clinical. The terms of the transaction were not disclosed.
Missing: OncoBay Clinical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: OncoBay Clinical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest OncoBay Clinical News
Feb 28, 2023
B2RLaw has advised the Moffitt Cancer Center and its for-profit subsidiary OncoBay Clinical on Clinscience's USD 33.5 million investment in OncoBay.
OncoBay Clinical Frequently Asked Questions (FAQ)
When was OncoBay Clinical founded?
OncoBay Clinical was founded in 2019.
Where is OncoBay Clinical's headquarters?
OncoBay Clinical's headquarters is located at 10902 McKinley Drive, Tampa.
What is OncoBay Clinical's latest funding round?
OncoBay Clinical's latest funding round is Corporate Majority.
Who are the investors of OncoBay Clinical?
Investors of OncoBay Clinical include NEUCA.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.